Ultrasound Response to SNAG in Chronic Medial Epicondylitis Treatment
SNAG ( sustained natural apopheseal glide )
Elbow Tendinopathy+5
+ Elbow Injuries
+ Arm Injuries
Treatment Study
Summary
Study start date: September 8, 2025
Actual date on which the first participant was enrolled.This study focuses on finding new ways to treat medial epicondylitis, also known as golfer's elbow, which causes pain on the inside of the elbow, especially during certain movements like bending the wrist. This condition can lead to difficulties in performing everyday tasks and work-related activities due to pain and other functional issues. Researchers aim to explore whether certain treatments applied to the neck and upper back can improve the condition of the tendons in individuals with this elbow pain. By understanding these effects, the study hopes to offer better treatment options that might reduce pain and improve the function of the elbow and shoulder in affected individuals. Participants in the study will undergo a specified treatment involving physical therapy techniques targeting the neck and upper back regions. The researchers will measure how this treatment affects the structure of the tendons and blood flow in the affected area by using ultrasound technology. They will also assess changes in pain levels and the ability to perform tasks using the shoulder and elbow. Before and after participating in the study, the strength of the hand muscles and pain levels will be evaluated to determine the effectiveness of the treatment. This comprehensive approach aims to provide a clearer understanding of how these interventions might help alleviate symptoms and improve daily functioning for those with medial epicondylitis.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 35 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Age ranges from 35 to 50 years old in both sexes. * Patients with LE that diagnosed by orthopedist. * Pain onset is more than 3 months appear primarily with use or rest or in both, also , it appear with deep palpation of the medial epicondyle . Exclusion Criteria: * • Rheumatoid Arthritis . * Skin infection. * History of previous elbow surgery. * Any pathology in the shoulder joint. * Neurologic deficit in upper extremity. * Cervical disc prolapse and radiculopathy C5,6. * Dislocation of elbow joint. * Recent fractures of upper extremity. * Arthrosis of the radiohumeral joint. * Osteochondritis dissecans. * Osteonecrosis. * Plica synovialis. * Participants receiving other treatment, in the form of physical therapy or medication, for the duration of the study that may interfere with the results of this study.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Faculty of Physical Therapy, Beni-Suef University
Banī Suwayf, EgyptOpen Faculty of Physical Therapy, Beni-Suef University in Google Maps